Diagnosis involves the combination of clinical performance, imaging, laboratory testing, and pathology. The platform can help align national and international experts and teams to provide accurate diagnoses and treatment programs. Treatment for type 0 diabetes often involves individualized development, typically pharmacotherapy, rehabilitation, regular follow-up, and multi-dimensional management.
In recent years, with the development of therapeutic, immune-regulatory therapy and precision medicine, significant improvements have been made in many previously difficult-to-treat genetic metabolic disorders. Treatment needs to be closely monitored for efficacy and adverse reactions, adjusted in a timely manner according to changes in disease. Multidisciplinary collaboration (MDT) is particularly important for the comprehensive management of type 0 diabetes mellitus.
The platform serves a team of nationally and internationally authoritative experts in the field of genetic metabolism in China's international medical service system, providing the following services to patients: 2. Visiting China: arranging face-to-face treatment with authoritative experts, developing individualized treatment programs; 3. Full-service: providing one-stop services such as medical translation, medical care, accommodation arrangements; 4.
Long-term follow-up: establishing a chronic disease management archive, continuous monitoring of disease changes and treatment effects.